In contrast, there are also reports about increased levels of NUCB2/nesfatin-1 peptide in serum in patients suffering from GDM [260] and in the cord blood of babies born to mothers with GDM [260,261], resulting in nesfatin-1 being an independent risk factor for GDM [260]. This evidence concerns the gene NUCB2 and gestational diabetes.